Crossmark

Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature

Crossref DOI link: https://doi.org/10.1186/s12876-022-02121-3

Published Online: 2022-02-05

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Studentova, Hana https://orcid.org/0000-0003-2105-9258
Volakova, Jindriska

Spisarova, Martina

Zemankova, Anezka

Aiglova, Kvetoslava

Szotkowski, Tomas

Melichar, Bohuslav
Funding

Funding for this research was provided by:

Grantová Agentura České Republiky (17-16614S)
License Information

Text and Data Mining valid from 2022-02-05

Version of Record valid from 2022-02-05
More Information

Article History

Received: 30 April 2021

Accepted: 25 January 2022

First Online: 5 February 2022

Declarations

:

: Our institution does not require ethics approval for case reports.

: Written informed consent was obtained from both patients for publication before treatment initiation. It is available on request.

: The authors state that there are no competing interests regarding the publication of this article.

Document is current

Any future updates will be listed below